GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.05.23	GSK To Sell Up To 2.5% Of Haleon's Shares (RTTNews)
04.05.23	FDA Approves GSK's Arexvy, World's First RSV Vaccine For Older Adults (RTTNews)
27.04.23	GSK-Aktie steigt: GSK hofft auf Zulassung von RSV-Impfung in Europa (AWP) Der Pharmakonzern GSK kann sich Hoffnungen auf eine Zulassung in Europa für seine RSV-Impfung bei älteren Erwachsenen machen.» mehr
27.04.23	GSK's Respiratory Syncytial Virus Older Adult Vaccine Candidate Gets Positive CHMP Opinion (RTTNews)
26.04.23	Schwacher Jahresauftakt für GSK nach starkem Vorjahr (AWP)
26.04.23	GSK Q1 Adj. Operating Profit Stable At CER, Affirms 2023 Guidance (RTTNews)
18.04.23	GSK To Buy BELLUS Health In US$2.0 Bln Deal (RTTNews)
17.04.23	GSK Plc: Gepotidacin Shows Non-inferiority To Nitrofurantoin In EAGLE-2 And EAGLE-3 Phase III Trials (RTTNews)
30.03.23	GSK, SCYNEXIS Ink Exclusive Licence Agreement For Brexafemme (RTTNews)
28.03.23	GSK Announces Positive Results From Phase III Trial Of Jemperli Combination In Endometrial Cancer (RTTNews)
28.03.23	Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemother... (PR Newswire)
24.03.23	GSK Disagrees With Ruling By California State Court - Quick Facts (RTTNews)
14.03.23	GSK Announces Positive Phase III Data For 5-in-1 Meningococcal ABCWY Vaccine Candidate (RTTNews)
14.03.23	GSK : China Accepts Regulatory Submission For Nucala In Severe Eosinophilic Asthma (RTTNews)
02.03.23	FDA Panel Backs GSK's RSV Vaccine For Older Adults (RTTNews)
10.02.23	GSK Plc: FDA Grants Approval For Jemperli For Patients With DMMR Recurrent Endometrial Cancer (RTTNews)
10.02.23	US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer (PR Newswire)
02.02.23	FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis (RTTNews)
01.02.23	Pharmakonzern GSK bleibt dank Impfstoffgeschäft optimistisch für 2023 (AWP)
01.02.23	GSK Q4 Profit Climbs, Sees Growth In FY23; Says Confident Of FY26 View (RTTNews)
01.02.23	GSK: FDA Grants Orphan Drug Designation To Benlysta For Treatment Of Rare Autoimmune Disease (RTTNews)
29.01.23	Biotech Stocks Facing FDA Decision In February 2023 (RTTNews)
05.01.23	WuXi Enters Into License Deal With GSK On Multiple Novel Bi- & Multi-specific T Cell Engagers (RTTNews)
05.01.23	WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers (PR Newswire)
07.12.22	GSK Welcomes MDL Court Ruling - Quick Facts (RTTNews)
02.12.22	GSK Plc: Jemperli RUBY Phase III Trial Meets Primary Endpoint - Quick Facts (RTTNews)
22.11.22	GSK Initiates Process For Withdrawal Of US Marketing Authorization For Blood Cancer Drug Blenrep (RTTNews)
11.11.22	GSK To Restrict Second-line Maintenance Indication For Zejula In U.S. (RTTNews)
11.11.22	European Commission Approves Sanofi-GSK COVID Booster Vaccine (RTTNews)
07.11.22	GSK Plc: DREAMM-3 Phase III Trial For Blenrep Fails To Meet Primary Endpoint (RTTNews)
02.11.22	Pharmakonzern GSK mit überraschend guten dritten Quartal (AWP)
02.11.22	GSK Q3 Profit From Cont. Opns Down; Lifts 2022 Sales Growth Outlook (RTTNews)
02.11.22	GSK's Respiratory Syncytial Virus Older Adult Vaccine Candidate Gets FDA's Priority Review (RTTNews)
28.10.22	GSK: EMA Validates ViiV Healthcare's MAA For Cabotegravir Long-acting Injectable For HIV Prevention (RTTNews)
28.10.22	ViiV Healthcare : EMA Validates MAA For Cabotegravir Long-acting Injectable For HIV Prevention (RTTNews)
27.10.22	GSK: FDA Advisory Committee Supports Daprodustat Use In Adult Dialysis Patients With Anaemia Of CKD (RTTNews)
27.10.22	GSK Decides Not To Progress With Submissions For Otilimab In Treatment Of Rheumatoid Arthritis (RTTNews)
26.10.22	Biotech Stocks Facing FDA Decision In November 2022 (RTTNews)
21.10.22	GSK : Japan Accepts Regulatory Submission For RSV Older Adult Vaccine Candidate (RTTNews)
17.10.22	GSK : FDA Oks Menveo In Single-vial Presentation To Prevent Disease Caused By Meningococcal Bacteria (RTTNews)
10.10.22	FDA Approves GSK's Vaccine For Use In Pregnancy To Prevent Whooping Cough In Infants (RTTNews)
30.09.22	Biotech Stocks Facing FDA Decision In October 2022 (RTTNews)
22.09.22	GSK : FDA Panel To Review Zejula Data From Phase III Trial In Recurrent Ovarian Cancer (RTTNews)
22.09.22	GSK To Receive Licence From Spero To Develop, Commercialise Tebipenem Pivoxil HBr (RTTNews)
19.09.22	Theravance To Buy Back $250 Mln Of Shares (RTTNews)
06.09.22	GSK: FDA Sets Advisory Committee Meeting To Review NDA For Daprodustat - Quick Facts (RTTNews)
29.08.22	IDEAYA Reports Preclinical Development Milestone In Ongoing IND-enabling Studies With GSK (RTTNews)
17.08.22	GSK: FDA Accepts New Drug Application For Momelotinib To Treat Myelofibrosis (RTTNews)
17.08.22	GSK Plc Issues Statement On Voluntary Dismissal To Be Filed In Bayer Case (RTTNews)
12.08.22	GSK: FDA, EMA Conclude No Evidence Of Association Between Ranitidine Therapy And Cancer Development (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft